Skip to main content
BIOME AUSTRALIA LIMITED logo

BIOME AUSTRALIA LIMITED — Investor Relations & Filings

Ticker · BIO ISIN · AU0000184137 ASX Manufacturing
Open in API
Filings indexed 303 across all filing types
Latest filing 2025-06-29 Regulatory Filings
Country AU Australia
Listing ASX BIO

About BIOME AUSTRALIA LIMITED

https://www.biomeaustralia.com

Biome Australia Limited is a microbiome health company specializing in the development and distribution of evidence-based probiotics and complementary medicines. The company focuses on translating microbiome science into accessible healthcare solutions through its flagship brand, Activated Probiotics. Its product portfolio consists of condition-specific formulations designed to address various health areas, including digestive health, immune system support, bone density, and mental wellbeing via psychobiotics. Biome Australia prioritizes clinical research and collaborates with global experts to ensure the efficacy of its formulations. The company’s distribution strategy centers on a network of community pharmacies and independent health practitioners, providing professional-grade supplements to the retail and clinical markets.

Recent filings

Filing Released Lang Actions
Secondary Trading Notice 2 pages 257.2KB
Regulatory Filings Classification · 95% confidence The document is an ASX announcement dated 30 June 2025 regarding the issuance of shares under the company's Employee Incentive Plan and advisory services. It references compliance with the Corporations Act 2001, specifically section 708A(5), which relates to secondary trading notices and exemptions from disclosure requirements for certain share issuances. The document does not contain financial statements or detailed financial data but serves as a regulatory notice about share issuance and trading restrictions. The length is relatively short (3134 characters), and it is clearly an announcement rather than a full report. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2025-06-29 English
Proposed issue of securities - BIO 5 pages 17.2KB
Share Issue/Capital Change Classification · 100% confidence The document is titled 'Appendix 3B - Proposed issue of securities' and contains detailed information about a proposed placement or other type of securities issue by Biome Australia Limited. It includes specifics such as the number of securities to be issued, the issue date, consideration details, and compliance with ASX Listing Rules. The content focuses on the announcement of a new securities issuance rather than financial results, management changes, or other report types. This matches the definition of a Share Issue/Capital Change announcement. The document length is about 5971 characters, which is sufficient to contain substantive details about the capital change. Therefore, the appropriate classification is 'SHA' for Share Issue/Capital Change.
2025-06-24 English
Investor Webinar 3 pages 306.1KB
Investor Presentation Classification · 90% confidence The document is an ASX announcement dated 29th May 2025 inviting investors to register for an upcoming investor webinar scheduled for 5th June. It includes details about the webinar, the company's business, contact information, and forward-looking statements. There are no financial statements, detailed financial data, or comprehensive report content. The document serves as an invitation and business update notice rather than a full report or transcript. It is not a transcript of the webinar itself, nor is it a formal financial report or regulatory filing. Given the nature of the content, it fits best as an Investor Presentation (IP) announcement or invitation, but since it is primarily an announcement of a webinar event with business updates, the closest classification is Investor Presentation (IP). Confidence is high due to clear indicators of an investor-focused presentation event.
2025-05-28 English
Board Update 4 pages 321.2KB
Board/Management Information Classification · 100% confidence The document is an ASX announcement dated 21 May 2025, detailing the appointment of Geoff Sam as Chairman of the Board of Directors of Biome Australia Limited. It discusses the resignation of the previous chair, the qualifications and experience of the new chair, and includes statements from the new chair and the managing director. There are no financial statements, earnings data, or detailed financial analysis present. The content focuses solely on changes in the company's board of directors. Therefore, this document fits the category of Board/Management Information (MANG). The document length is sufficient and contains substantive information about management changes, not just a brief notice or report publication announcement.
2025-05-20 English
Final Director's Interest Notice 2 pages 194.1KB
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3Z Final Director’s Interest Notice' and references ASX listing rule 3.19A.3 and section 205G of the Corporations Act. It details the director's relevant interests in securities, including shares held directly and indirectly, and notes the date the director ceased to be a director. This is a report of personal share transactions or holdings by a company director, which fits the definition of Director's Dealing filings. The document length is short and focused solely on director share interests, with no financial results or other report content. Therefore, the appropriate classification is Director's Dealing (DIRS).
2025-05-20 English
Biome Launches Activated Therapeutics Range 7 pages 684.7KB
Regulatory Filings Classification · 95% confidence The document is an ASX announcement dated 6 May 2025 from Biome Australia Limited about launching a new brand called Activated Therapeutics. It details new product offerings, their therapeutic applications, market positioning, and strategic rationale. The document is a corporate announcement focused on product launch and business strategy rather than financial results, regulatory filings, or shareholder meeting materials. It does not contain financial statements, audit information, voting results, or executive changes. It is not a report or transcript but a business update announcement. Therefore, the most appropriate classification is a Regulatory Filing (RNS), which serves as a general category for miscellaneous corporate announcements that do not fit other specific categories.
2025-05-05 English

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.